This bill amends Minnesota Statutes 2024, specifically section 256B.0625, subdivision 13f, to prohibit the use of prior authorization and step therapy for drugs approved by the United States Food and Drug Administration for the treatment of opioid use disorder under medical assistance. The new legal language explicitly states that, notwithstanding any existing laws, prior authorization or step therapy shall not be required for this class of drugs, ensuring that individuals seeking treatment for opioid use disorder can access necessary medications without additional barriers.

Additionally, the bill makes several deletions and modifications to existing provisions regarding prior authorization for various drugs. Notably, it removes the requirement for prior authorization for liquid methadone and clarifies the process for prior authorization related to other medications, including those prescribed for patients using enteral tubes. The changes aim to streamline access to essential medications while maintaining oversight for other drug categories.

Statutes affected:
Introduction: 256B.0625